Gynecologic Cancer
Clinical Insights
mCODE: Improving data sharing to enhance cancer care
Clinical Insights
Genetic testing for breast and ovarian cancer: What has changed and what still needs to change?
Dr. Alan Lyss reviews a study that revealed trends in genetic testing over time.
From the Journals
Ovarian cancer prevention: How patients decide on surgery
Twenty-four women reveal how they made a difficult decision.
News from the FDA/CDC
Bladder cancer indication withdrawn for durvalumab
AstraZeneca has withdrawn durvalumab’s indication for the treatment of metastatic bladder cancer after a phase 3 trial showed no survival benefit...
From the Journals
Prophylactic NPWT may not improve complication rate after gynecologic surgery
The study results do not entirely resolve the question in patients with higher BMI, according to Dr. Sarah Temkin.
Opinion
Endometriosis-associated ovarian cancer
A woman with endometriosis has a two- to threefold increased risk of developing epithelial ovarian cancer, compared with nonaffected women.
From the Journals
Pap test/cervical swab samples can reveal ovarian cancer biomarkers
Clinical Insights
How has the pandemic affected rural and urban cancer patients?
From the Journals
Prophylactic NPWT may not improve complication rate after gynecologic surgery
The low rate of wound complications in the study could be explained by patient selection.
Conference Coverage
CXR-Net: An AI-based diagnostic tool for COVID-19
The tool showed promise in a pilot study.
Conference Coverage
Asymptomatic screening for COVID-19 in cancer patients still debated
Less than 1% of cancer patients studied were COVID-19 positive on asymptomatic screening.